Denmark vs Developing regions: Proportion of the target population who received a 3rd dose of
Denmark
96.0%
in 2024
Developing regions
66.0%
in 2024
Denmark rank
15th
Developing regions rank
12th
Proportion of the target population who received a 3rd dose of over time
- Denmark
- Developing regions
How they compare
Denmark currently reports 96.0% against 66.0% in Developing regions, a difference of 30.0%.
That makes Denmark's figure about 1.5 times Developing regions's.
Across all 16 years both countries report, Denmark has been ahead every year.
Denmark ranks 15th and Developing regions ranks 12th of 136 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Developing regions | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.0% | 3.0% | 83.0% | Denmark |
| 2010s | 93.3% | 28.4% | 64.9% | Denmark |
| 2020s | 96.2% | 56.4% | 39.8% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Denmark or Developing regions?
- Denmark, at 96.0% against 66.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Denmark and Developing regions?
- 30.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Developing regions?
- 16 years are reported by both, from 2009 to 2024.
- How do Denmark and Developing regions rank globally for proportion of the target population who received a 3rd dose of?
- Denmark ranks 15th and Developing regions ranks 12th of 136 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.